T. Rowe Price Funds OEIC China Evolution Equity Fund C Acc 9 GBP |
Performance History | 31/03/2025 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | - | -15.0 | -20.8 | 14.3 | 2.4 |
![]() | +/-Cat | - | 0.7 | -0.4 | 0.0 | -5.4 |
![]() | +/-B’mrk | - | -4.7 | -5.7 | -5.6 | -8.9 |
Category: China Equity | ||||||
Category Benchmark: Morningstar China TME NR USD |
Key Stats | ||
NAV 02/04/2025 | GBP 7.60 | |
Day Change | 0.30% | |
Morningstar Category™ | China Equity | |
IA (formerly IMA) Sector | China/Greater China | |
ISIN | GB00BMHRMM32 | |
Fund Size (Mil) 02/04/2025 | GBP 5.41 | |
Share Class Size (Mil) 02/04/2025 | GBP 0.74 | |
Max Initial Charge | - | |
Ongoing Charge 10/02/2025 | 0.79% |
Investment Objective: T. Rowe Price Funds OEIC China Evolution Equity Fund C Acc 9 GBP |
To increase the value of its shares through growth in the value of its investments over the long term (a minimum of 5 years). The fund is actively managed and invests in a portfolio of shares of Chinese companies and may have significant exposure to smaller capitalisation companies (up to 45% of the total assets of the fund, where by smaller capitalisation the investment manager considers companies with a market capitalization below USD 5 billion). The fund aims to invest in companies with high returns on capital in the long-term, focusing on opportunities in the evolving Chinese economy. The fund invests at least 80% of total assets in shares and related securities issued by companies that are either incorporated in China, Hong Kong, Macau or Taiwan, or conduct most of their business in China. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Wenli Zheng 10/12/2021 | ||
Inception Date 10/12/2021 |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI China All Shares NR USD | Morningstar China TME NR USD |
Portfolio Profile for T. Rowe Price Funds OEIC China Evolution Equity Fund C Acc 9 GBP | 28/02/2025 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 5.14 |
![]() | ![]() | 3.21 |
![]() | ![]() | 2.93 |
![]() | ![]() | 2.78 |
![]() | ![]() | 2.64 |
![]() | ||
![]() ![]() ![]() | ||
T. Rowe Price Funds OEIC China Evolution Equity Fund C Acc 9 GBP |
Growth Of 1000 (GBP) | 31/03/2025 |
|
Annual Returns (GBP) | 31/03/2025 | |||||||
2022 | 2023 | 2024 | 31/03 | |||||
Price Return | -15.04 | -20.82 | 14.28 | 2.38 | ||||
+/- Category | 0.74 | -0.44 | -0.02 | -5.44 | ||||
+/- Category Index | -4.65 | -5.74 | -5.57 | -8.89 | ||||
% Rank in Category | 48 | 52 | 51 | 89 |
Trailing Returns (GBP) | 02/04/2025 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.30 | -0.08 | 0.58 |
1 Week | 0.35 | 0.87 | 1.84 |
1 Month | 0.52 | 1.37 | 0.87 |
3 Months | 4.92 | -3.62 | -7.75 |
6 Months | 1.65 | -4.74 | 0.12 |
YTD | 3.58 | -4.95 | -7.97 |
1 Year | 9.79 | -14.42 | -22.16 |
3 Years Annualised | -1.39 | 0.49 | -5.20 |
5 Years Annualised | - | - | - |
10 Years Annualised | - | - | - |
Category: China Equity | |||
Category Index: Morningstar China TME NR USD |
Quarterly Returns (GBP) | 31/03/2025 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2025 | 2.38 | - | - | - |
2024 | 4.66 | 5.99 | 4.97 | -1.86 |
2023 | -0.82 | -12.32 | -1.46 | -7.60 |
2022 | -16.59 | 13.86 | -11.74 | 1.35 |
Morningstar Rating™(Relative to Category) | 28/02/2025 | ||||||||||||||||||||
| |||||||||||||||||||||
Category : China Equity | Click here to see our Methodology |
Volatility Measurements | 31/03/2025 | ||||||||||
| |||||||||||
Modern Portfolio Statistics | 31/03/2025 | 31/03/2025 |
Standard Index | Best Fit Index | |
Morningstar China TME NR USD | Morningstar China TME NR USD | |
3-Yr Beta | 0.84 | 0.86 |
3-Yr Alpha | -6.22 | -8.30 |
Investment Style Details | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
Category: China Equity |
Asset Allocation | 28/02/2025 |
|
World Regions | 28/02/2025 | ||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||
Category: China Equity |
Sector Weightings | 28/02/2025 | ||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||
Category: China Equity |
Top 10 Holdings | 28/02/2025 |
Portfolio NEW | |
Total Number of Equity Holdings | 59 |
Total Number of Bond Holdings | 0 |
Assets in Top 10 Holdings | 29.09 |
Name | Sector | Country | % of Assets | ||
![]() | ![]() | China | 5.14 | ||
![]() | ![]() | China | 3.21 | ||
![]() | ![]() | China | 2.93 | ||
![]() | ![]() | China | 2.78 | ||
![]() | ![]() | China | 2.64 | ||
![]() | ![]() | China | 2.63 | ||
![]() | ![]() | China | 2.47 | ||
![]() | ![]() | China | 2.45 | ||
![]() | ![]() | China | 2.43 | ||
![]() | ![]() | China | 2.41 | ||
![]() ![]() ![]() | |||||
Category: China Equity | |||||
Management | ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
|
![]() | |
Biography | |
Wenli Zheng has been chairman of the committee since 2019. He joined the Firm in 2008 and his investment experience dates from that time. Wenli completed an internship at T. Rowe Price in 2007 and has been with the firm since 2008. Prior to joining T. Rowe Price, he was a strategy consultant at Capgemini in China. Wenli earned an M.B.A. from the University of Chicago and a dual bachelor's degree in industrial engineering and economics from the South China University of Technology. |
Fees and Expenses | ||||||||||||
|
Purchase Details | ||||||||
| ||||||||
|